54197 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
00:54 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | Buy | C$200.00→ C$217.00+8.5% |
|
Aug 12
00:54 UTC
|
CRWV
CoreWeave
|
◎ Target | Mark Murphy ★★★☆☆ #1012 | Neutral | $105.00→ $110.00+4.8% |
|
Aug 12
00:54 UTC
|
CRBG
Corebridge Financial
|
◎ Target | Ryan Krueger ★★★★★ #199 | Outperform | $40.00→ $43.00+7.5% |
|
Aug 12
00:54 UTC
|
CPA
Copa
|
◎ Target | Alberto Valerio ★★☆☆☆ #2321 | Buy | $195.00→ $185.00-5.1% |
|
Aug 12
00:54 UTC
|
COR
Cencora
|
◎ Target | Stephen Baxter ★★★★★ #178 | Overweight | $331.00→ $395.00+19.3% |
|
Aug 12
00:54 UTC
|
COP
ConocoPhillips
|
◎ Target | Biju Perincheril not yet tracked | Positive | $155.00→ $161.00+3.9% |
|
Aug 12
00:54 UTC
|
CON
Concentra Group Holdings Parent
|
◎ Target | Stephen Baxter ★★★★★ #178 | Overweight | $28.00→ $40.00+42.9% |
|
Aug 12
00:54 UTC
|
CODI
Compass Diversified
|
◎ Target | Lance Vitanza ★★★☆☆ #1853 | Buy | $12.50→ $18.00+44.0% |
|
Aug 12
00:54 UTC
|
COAG
Hemab Therapeutics
|
◎ Target | Emily Bodnar ★☆☆☆☆ #2997 | Buy | $52.00→ $60.00+15.4% |
|
Aug 12
00:54 UTC
|
CMRC
Commerce.com
|
◎ Target | Raimo Lenschow ★★★★☆ #562 | Underweight | $3.00→ $2.00-33.3% |
|
Aug 12
00:54 UTC
|
CHRW
C.H. Robinson Worldwide
|
◎ Target | David Vernon ★★★★☆ #714 | Market Perform | $153.00→ $151.00-1.3% |
|
Aug 12
00:54 UTC
|
CHH
Choice Hotels International
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1052 | Neutral | $110.00→ $115.00+4.5% |
|
Aug 12
00:54 UTC
|
CF
Canaccord Genuity Group
|
◎ Target | firm only | Buy | C$16.00→ C$18.00+12.5% |
|
Aug 12
00:54 UTC
|
CEVA
Ceva
|
◎ Target | Martin Yang ★★★☆☆ #2055 | Outperform | $42.00→ $38.00-9.5% |
|
Aug 12
00:54 UTC
|
CEVA
Ceva
|
◎ Target | Kevin Cassidy ★★☆☆☆ #2707 | Buy | $45.00→ $49.00+8.9% |
|
Aug 12
00:54 UTC
|
CEVA
Ceva
|
◎ Target | Joshua Buchalter ★★☆☆☆ #2754 | Buy | $55.00→ $45.00-18.2% |
|
Aug 12
00:54 UTC
|
CBLL
CeriBell
|
◎ Target | William Plovanic ★★★★☆ #608 | Buy | $25.00→ $26.00+4.0% |
|
Aug 12
00:54 UTC
|
CATX
Perspective Therapeutics
|
◎ Target | Biren Amin ★☆☆☆☆ #3102 | Overweight | $16.00→ $14.00-12.5% |
|
Aug 12
00:54 UTC
|
CAR.UN
Canadian Apartment Properties REIT
|
◎ Target | firm only | Outperform | C$48.00→ C$43.00-10.4% |
|
Aug 12
00:54 UTC
|
CAMT
Camtek
|
◎ Target | Shane Brett not yet tracked | Equal Weight | $167.00→ $165.00-1.2% |
|
Aug 12
00:54 UTC
|
CACI
CACI International
|
◎ Target | John Godyn ★★★☆☆ #1248 | Neutral | $519.00→ $648.00+24.9% |
|
Aug 12
00:54 UTC
|
BTDR
Bitdeer Technologies Group
|
◎ Target | John Todaro ★☆☆☆☆ #3195 | Buy | $22.00→ $20.00-9.1% |
|
Aug 12
00:54 UTC
|
BKV
BKV
|
◎ Target | Betty Jiang ★★★☆☆ #1207 | Overweight | $35.00→ $36.00+2.9% |
|
Aug 12
00:54 UTC
|
BKE
Buckle
|
◎ Target | Mauricio Serna ★★★★★ #236 | Neutral | $47.00→ $46.00-2.1% |
|
Aug 12
00:54 UTC
|
BKD
Brookdale Senior Living
|
◎ Target | Andrew Mok not yet tracked | Overweight | $18.00→ $17.00-5.6% |
|
Aug 12
00:54 UTC
|
BHVN
Biohaven
|
◎ Target | Leonid Timashev ★★★☆☆ #1417 | Outperform | $22.00→ $23.00+4.5% |
|
Aug 12
00:54 UTC
|
BBY
Best Buy
|
◎ Target | Zachary Fadem ★★★☆☆ #1265 | Equal Weight | $65.00→ $85.00+30.8% |
|
Aug 12
00:54 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Derek Archila ★★★☆☆ #2026 | Overweight | $98.00→ $102.00+4.1% |
|
Aug 12
00:54 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Geoff Meacham ★★★☆☆ #1105 | Buy | $101.00→ $104.00+3.0% |
|
Aug 12
00:54 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Sean Laaman ★★★☆☆ #1057 | Overweight | $98.00→ $97.00-1.0% |
|
Aug 12
00:54 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Tyler Van Buren ★★☆☆☆ #2468 | Buy | $95.00→ $110.00+15.8% |
|
Aug 12
00:54 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Biren Amin ★☆☆☆☆ #3102 | Overweight | $111.00→ $115.00+3.6% |
|
Aug 12
00:54 UTC
|
BATS
British American Tobacco
|
◎ Target | firm only | Underperform | GBX 3,600→ GBX 3,800+5.6% |
|
Aug 12
00:54 UTC
|
B
Barrick Mining
|
◎ Target | firm only | Buy | $61.00→ $59.00-3.3% |
|
Aug 12
00:54 UTC
|
B
Barrick Mining
|
◎ Target | Lawson Winder ★★☆☆☆ #2282 | Buy | $56.00→ $54.00-3.6% |
|
Aug 12
00:54 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Yatin Suneja ★☆☆☆☆ #2924 | Buy | $260.00→ $275.00+5.8% |
|
Aug 12
00:54 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Benjamin Burnett ★★★☆☆ #1834 | Overweight | $255.00→ $256.00+0.4% |
|
Aug 12
00:54 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Leonid Timashev ★★★☆☆ #1417 | Outperform | $304.00→ $297.00-2.3% |
|
Aug 12
00:54 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Sean Laaman ★★★☆☆ #1057 | Equal Weight | $242.00→ $251.00+3.7% |
|
Aug 12
00:54 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Ami Fadia ★★★☆☆ #2060 | Buy | $267.00→ $268.00+0.4% |
|
Aug 12
00:54 UTC
|
AURA
Aura Biosciences
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2639 | Buy | $24.00→ $18.00-25.0% |
|
Aug 12
00:54 UTC
|
ASTS
AST SpaceMobile
|
◎ Target | Christopher Schoell not yet tracked | Neutral | $80.00→ $78.00-2.5% |
|
Aug 12
00:54 UTC
|
ASTS
AST SpaceMobile
|
◎ Target | Alexander Potter ★☆☆☆☆ #3127 | Overweight | $100.00→ $98.00-2.0% |
|
Aug 12
00:54 UTC
|
ASTS
AST SpaceMobile
|
◎ Target | Colin Canfield ★★☆☆☆ #2736 | Overweight | $80.00→ $90.00+12.5% |
|
Aug 12
00:54 UTC
|
ASST
Strive
|
◎ Target | Mike Colonnese ★☆☆☆☆ #3029 | Buy | $37.00→ $36.00-2.7% |
|
Aug 12
00:54 UTC
|
ASPN
Aspen Aerogels
|
◎ Target | David Anderson ★★☆☆☆ #2285 | Underweight | $4.00→ $5.00+25.0% |
|
Aug 12
00:54 UTC
|
APLE
Apple Hospitality REIT
|
◎ Target | Jay Kornreich ★★★★☆ #795 | Overweight | $16.00→ $18.00+12.5% |
|
Aug 12
00:54 UTC
|
APEI
American Public Education
|
◎ Target | Eric Martinuzzi ★★★☆☆ #1779 | Buy | $62.00→ $64.00+3.2% |
|
Aug 12
00:54 UTC
|
APA
APA
|
◎ Target | Biju Perincheril not yet tracked | Positive | $45.00→ $47.00+4.4% |
|
Aug 12
00:54 UTC
|
AN
AutoNation
|
◎ Target | Bill Selesky ★★★☆☆ #1374 | Buy | $241.00→ $246.00+2.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.